NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human primary cells. The Nanostraw technology, exclusively licensed from Stanford University, provides direct intracellular access into hard-to-transfect primary human cells for efficient delivery of any cargo. Using a physical, non-perturbative mechanism for delivery, the challenges … Continue reading NAVAN Technologies
Medicine Koubou 359, LLC dedicates its effort in small molecule drug discovery
At Filtricine, Inc., we develop a drug-free cancer therapy based on nutrient deprivation. By taking away the nutrients that are necessary only for cancer cells, our MEAD therapy is expected to clear cancer cells in the patient’s body within weeks, but leaves normal body function unharmed. We are at preclinical stage and expect to get … Continue reading Filtricine
Cognitive Genetics LLC (CogGen) is a pre-commercial consumer healthcare company developing the first pre-symptomatic genetic screening panel for predisposition to the three most common Learning Disabilities (LDs): Reading Disability (Dyslexia), Specific Language Impairment (SLI) & Speech Sound Disorder (SSD) CogGen’s proprietary technology combined with it’s unique quantitative modeling allows pre-symptomatic screening resulting in early intervention … Continue reading Cognitive Genetics Inc.
Avail bio is a precision medicine oncology startup focused on optimizing patient response to cancer therapeutics and minimizing the risk of adverse events.
Astarte Medical is developing NICUtrition®, a software and data analytics platform optimizing feeding, nutrition, and gut health for preterm infants. NICUtrition® Guidance is a patient safety and compliance tool standardizing the practice of feeding in the NICU. Our flagship product, NICUtrition® MAGI, introduces the microbiome and gut inflammation score using predictive analytics to stratify infants … Continue reading Astarte Medical
Algen Biotechnologies, Inc., a therapeutic discovery company, is building an intelligent platform to decode functional gene networks for drug discovery.